Color vision testing during FAA medical examinations remains one of the more confusing and inconsistently applied elements of the certification process, and this pilot's experience highlights a gap between regulatory requirements and real-world AME practice. Under 14 CFR 67.103, 67.203, and 67.303, applicants for any class of medical certificate must demonstrate "the ability to perceive those colors necessary for the safe performance of airman duties." The FAA's Guide for Aviation Medical Examiners directs AMEs to administer color vision screening, typically via Ishihara pseudoisochromatic plates, at the initial examination. Whether it must be repeated at every subsequent exam is where practice diverges: FAA guidance generally holds that once a pilot has successfully passed a color vision test and it is documented in the airman medical file, retesting is not mandatory unless the AME has clinical reason to suspect a change in status or the applicant's record lacks clear documentation of a prior pass. In practice, however, AMEs retain discretion, and many use whatever equipment is on hand (including older combined vision-testing units with an integrated Ishihara function) regardless of whether the regulation strictly compels it, which is exactly the situation this pilot encountered.
For working and aspiring professional pilots, this is not merely a bureaucratic curiosity. A failed color vision screen does not automatically end a career, but it does trigger a more involved certification pathway. Pilots who fail the plate test at an AME's office can request additional FAA-approved testing methods, most notably the Farnsworth Lantern Test, the Operational Color Vision Test (OCVT) administered by FAA-designated facilities such as those in Oklahoma City or select regional test centers, or a Medical Flight Test demonstrating safe operational performance despite a color vision deficiency. Passing any of these alternate tests typically results in a Statement of Demonstrated Ability (SODA) or an operational limitation waiver noted on the certificate, allowing the pilot to fly with a "not valid for night flying and/or by color signal control" restriction removed or narrowed. The key point for pilots in this exact situation is that failing the office Ishihara test is the beginning of the process, not the end, and the FAA's Aerospace Medical Certification Division (AMCD) has well-established procedures for adjudicating these cases separately from the AME's initial pass/fail determination.
This matters broadly because color vision deficiency affects a meaningful percentage of the pilot population, roughly 8% of men have some form of red-green deficiency, and it disproportionately surfaces at moments like this: a pilot who held an unrestricted first-class medical since 2019 suddenly encountering a failed screen years later, despite no actual change in visual physiology. This underscores the importance of AMEs properly documenting prior color vision test results in FAA's electronic medical records system (via the 8500-8 application history) so that pilots are not needlessly re-tested on outdated equipment that may produce inconsistent results depending on plate condition, lighting, and machine calibration. It also highlights why pilots should proactively ask their AME what equipment is being used and whether their prior color vision determination is already on file before submitting to a fresh test that carries real career consequences if failed on a technicality.
More broadly, this incident reflects a persistent friction point in FAA aeromedical policy: examiner-level inconsistency in applying testing protocols, especially for legacy screening tools that many aviation ophthalmologists argue are outdated relative to modern operational color vision assessments. Similar friction exists across other borderline medical categories, including cardiac, mental health, and BasicMed pathway questions, where pilots increasingly turn to online forums and AOPA's medical certification advisory services for guidance before an exam rather than after a denial. For career-track pilots, especially those pursuing airline or Part 135 positions requiring a first-class medical, the practical lesson is to treat any medical exam as a process to manage proactively: understand what tests are legally required, request documentation of prior results, and know the OCVT/SODA/Medical Flight Test appeal pathway exists before walking into the AME's office, since a single failed screen with outdated equipment should not be a career-ending event if the proper alternate certification route is pursued promptly with AMCD.